

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | superoxide anion generation (GO:0042554) | 4.96230375 |
| 2 | regulation of hippo signaling (GO:0035330) | 4.67069277 |
| 3 | behavioral response to nicotine (GO:0035095) | 4.37132522 |
| 4 | polyketide metabolic process (GO:0030638) | 3.96594066 |
| 5 | doxorubicin metabolic process (GO:0044598) | 3.96594066 |
| 6 | daunorubicin metabolic process (GO:0044597) | 3.96594066 |
| 7 | detection of molecule of bacterial origin (GO:0032490) | 3.94339514 |
| 8 | negative regulation of mast cell activation (GO:0033004) | 3.90297204 |
| 9 | lymph vessel development (GO:0001945) | 3.85875274 |
| 10 | L-fucose catabolic process (GO:0042355) | 3.78113777 |
| 11 | fucose catabolic process (GO:0019317) | 3.78113777 |
| 12 | L-fucose metabolic process (GO:0042354) | 3.78113777 |
| 13 | lymphangiogenesis (GO:0001946) | 3.75385636 |
| 14 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.53402727 |
| 15 | indole-containing compound catabolic process (GO:0042436) | 3.49518660 |
| 16 | indolalkylamine catabolic process (GO:0046218) | 3.49518660 |
| 17 | tryptophan catabolic process (GO:0006569) | 3.49518660 |
| 18 | ganglion development (GO:0061548) | 3.42590764 |
| 19 | protein K11-linked deubiquitination (GO:0035871) | 3.42262997 |
| 20 | facial nerve structural organization (GO:0021612) | 3.41029739 |
| 21 | gamma-aminobutyric acid transport (GO:0015812) | 3.37299400 |
| 22 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.37106069 |
| 23 | detection of light stimulus involved in visual perception (GO:0050908) | 3.37106069 |
| 24 | indolalkylamine metabolic process (GO:0006586) | 3.36159471 |
| 25 | regulation of activation of Janus kinase activity (GO:0010533) | 3.34230916 |
| 26 | kynurenine metabolic process (GO:0070189) | 3.27068845 |
| 27 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 3.26517372 |
| 28 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 3.25059482 |
| 29 | regulation of action potential (GO:0098900) | 3.22374872 |
| 30 | tachykinin receptor signaling pathway (GO:0007217) | 3.20452232 |
| 31 | cellular ketone body metabolic process (GO:0046950) | 3.20257304 |
| 32 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.19198045 |
| 33 | monoubiquitinated protein deubiquitination (GO:0035520) | 3.15758517 |
| 34 | tryptophan metabolic process (GO:0006568) | 3.11631006 |
| 35 | ceramide catabolic process (GO:0046514) | 3.10240142 |
| 36 | reflex (GO:0060004) | 3.06705260 |
| 37 | regulation of interleukin-8 secretion (GO:2000482) | 3.03330582 |
| 38 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 3.01880467 |
| 39 | regulation of translation, ncRNA-mediated (GO:0045974) | 3.01880467 |
| 40 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 3.01880467 |
| 41 | dendritic cell chemotaxis (GO:0002407) | 3.00947060 |
| 42 | detection of external biotic stimulus (GO:0098581) | 3.00790806 |
| 43 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.99108373 |
| 44 | positive regulation of uterine smooth muscle contraction (GO:0070474) | 2.96333297 |
| 45 | photoreceptor cell maintenance (GO:0045494) | 2.95638731 |
| 46 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.95169144 |
| 47 | energy homeostasis (GO:0097009) | 2.94895210 |
| 48 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.93424965 |
| 49 | auditory receptor cell stereocilium organization (GO:0060088) | 2.93125125 |
| 50 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.92587531 |
| 51 | transepithelial transport (GO:0070633) | 2.90260056 |
| 52 | polyol transport (GO:0015791) | 2.89920000 |
| 53 | cranial nerve structural organization (GO:0021604) | 2.88665460 |
| 54 | inner ear receptor stereocilium organization (GO:0060122) | 2.88255140 |
| 55 | positive regulation of action potential (GO:0045760) | 2.85313045 |
| 56 | behavioral response to ethanol (GO:0048149) | 2.85177398 |
| 57 | cornea development in camera-type eye (GO:0061303) | 2.84768038 |
| 58 | neural tube formation (GO:0001841) | 2.84244594 |
| 59 | replicative senescence (GO:0090399) | 2.83832166 |
| 60 | platelet dense granule organization (GO:0060155) | 2.83478588 |
| 61 | positive regulation of protein kinase C signaling (GO:0090037) | 2.83210386 |
| 62 | neuronal action potential (GO:0019228) | 2.83142011 |
| 63 | membrane depolarization during action potential (GO:0086010) | 2.82282901 |
| 64 | detection of other organism (GO:0098543) | 2.81761895 |
| 65 | nucleotide transmembrane transport (GO:1901679) | 2.81075456 |
| 66 | mesenchymal cell differentiation involved in kidney development (GO:0072161) | 2.79762913 |
| 67 | mesenchymal cell differentiation involved in renal system development (GO:2001012) | 2.79762913 |
| 68 | indole-containing compound metabolic process (GO:0042430) | 2.79676728 |
| 69 | regulation of cellular extravasation (GO:0002691) | 2.79262787 |
| 70 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.76907184 |
| 71 | response to host immune response (GO:0052572) | 2.76907184 |
| 72 | sulfate transport (GO:0008272) | 2.75661210 |
| 73 | ketone body metabolic process (GO:1902224) | 2.75592567 |
| 74 | centriole assembly (GO:0098534) | 2.73648174 |
| 75 | negative regulation of myoblast differentiation (GO:0045662) | 2.68616786 |
| 76 | chemical homeostasis within a tissue (GO:0048875) | 2.68529080 |
| 77 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.68045520 |
| 78 | interkinetic nuclear migration (GO:0022027) | 2.67805623 |
| 79 | detection of bacterium (GO:0016045) | 2.67617416 |
| 80 | establishment of protein localization to Golgi (GO:0072600) | 2.66289870 |
| 81 | regulation of sarcomere organization (GO:0060297) | 2.65804772 |
| 82 | cellular anion homeostasis (GO:0030002) | 2.65376642 |
| 83 | serotonin metabolic process (GO:0042428) | 2.65333911 |
| 84 | superoxide metabolic process (GO:0006801) | 2.65003982 |
| 85 | adenine nucleotide transport (GO:0051503) | 2.64848791 |
| 86 | sulfate transmembrane transport (GO:1902358) | 2.63798966 |
| 87 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.62606341 |
| 88 | regulation of antigen processing and presentation (GO:0002577) | 2.61921418 |
| 89 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.61432188 |
| 90 | positive regulation of heat generation (GO:0031652) | 2.60257483 |
| 91 | response to pheromone (GO:0019236) | 2.58319981 |
| 92 | sulfation (GO:0051923) | 2.58254682 |
| 93 | retinal cone cell development (GO:0046549) | 2.57808542 |
| 94 | cell differentiation involved in metanephros development (GO:0072202) | 2.57767860 |
| 95 | regulation of uterine smooth muscle contraction (GO:0070472) | 2.57425580 |
| 96 | primary amino compound metabolic process (GO:1901160) | 2.57278565 |
| 97 | positive regulation of antigen processing and presentation (GO:0002579) | 2.57265950 |
| 98 | nonmotile primary cilium assembly (GO:0035058) | 2.56615799 |
| 99 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.54480664 |
| 100 | sprouting angiogenesis (GO:0002040) | 2.54247399 |
| 101 | amine catabolic process (GO:0009310) | 2.54115553 |
| 102 | cellular biogenic amine catabolic process (GO:0042402) | 2.54115553 |
| 103 | adaptation of signaling pathway (GO:0023058) | 2.53900598 |
| 104 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.53478186 |
| 105 | positive regulation of digestive system process (GO:0060456) | 2.53323215 |
| 106 | positive regulation by symbiont of host defense response (GO:0052509) | 2.52969188 |
| 107 | modulation by symbiont of host defense response (GO:0052031) | 2.52969188 |
| 108 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.52969188 |
| 109 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.52969188 |
| 110 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.52969188 |
| 111 | modulation by symbiont of host immune response (GO:0052553) | 2.52969188 |
| 112 | positive regulation of developmental pigmentation (GO:0048087) | 2.52676952 |
| 113 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 2.51234255 |
| 114 | natural killer cell activation involved in immune response (GO:0002323) | 2.50639850 |
| 115 | regulation of platelet aggregation (GO:0090330) | 2.50188084 |
| 116 | thyroid hormone metabolic process (GO:0042403) | 2.49306654 |
| 117 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.49111000 |
| 118 | benzene-containing compound metabolic process (GO:0042537) | 2.48694324 |
| 119 | glycolipid catabolic process (GO:0019377) | 2.48464555 |
| 120 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 2.48044642 |
| 121 | detection of biotic stimulus (GO:0009595) | 2.47780754 |
| 122 | protein localization to cilium (GO:0061512) | 2.46450154 |
| 123 | kidney morphogenesis (GO:0060993) | 2.46105704 |
| 124 | cellular response to ATP (GO:0071318) | 2.44992309 |
| 125 | histamine secretion (GO:0001821) | 2.44861448 |
| 126 | urinary tract smooth muscle contraction (GO:0014848) | 2.44694602 |
| 127 | signal peptide processing (GO:0006465) | 2.44530604 |
| 128 | nephron epithelium morphogenesis (GO:0072088) | 2.44363952 |
| 129 | nephron tubule morphogenesis (GO:0072078) | 2.44363952 |
| 130 | DNA deamination (GO:0045006) | 2.44188064 |
| 131 | dendritic cell migration (GO:0036336) | 2.43106952 |
| 132 | proline transport (GO:0015824) | 2.42878835 |
| 133 | dentate gyrus development (GO:0021542) | 2.42813789 |
| 134 | surfactant homeostasis (GO:0043129) | 2.42575361 |
| 135 | extracellular negative regulation of signal transduction (GO:1900116) | 2.42292129 |
| 136 | extracellular regulation of signal transduction (GO:1900115) | 2.42292129 |
| 137 | nucleotide transport (GO:0006862) | 2.41866975 |
| 138 | startle response (GO:0001964) | 2.40015386 |
| 139 | female gonad development (GO:0008585) | 2.39633536 |
| 140 | response to peptidoglycan (GO:0032494) | 2.39255363 |
| 141 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 2.39149046 |
| 142 | glycosphingolipid biosynthetic process (GO:0006688) | 2.39079582 |
| 143 | G-protein coupled receptor internalization (GO:0002031) | 2.38466976 |
| 144 | negative regulation of complement activation (GO:0045916) | 2.38062749 |
| 145 | adenosine metabolic process (GO:0046085) | 2.37882617 |
| 146 | lateral ventricle development (GO:0021670) | 2.37720061 |
| 147 | axoneme assembly (GO:0035082) | 2.37524305 |
| 148 | negative regulation of protein localization to cell surface (GO:2000009) | 2.37169507 |
| 149 | cyclic nucleotide catabolic process (GO:0009214) | 2.36936416 |
| 150 | venous blood vessel morphogenesis (GO:0048845) | 2.36601628 |
| 151 | cellular response to sterol (GO:0036315) | 2.36164927 |
| 152 | tyrosine phosphorylation of STAT protein (GO:0007260) | 2.35021323 |
| 153 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.34918625 |
| 154 | cilium morphogenesis (GO:0060271) | 2.34716944 |
| 155 | leukocyte tethering or rolling (GO:0050901) | 2.34291554 |
| 156 | negative regulation of systemic arterial blood pressure (GO:0003085) | 2.33498341 |
| 157 | regulation of pigment cell differentiation (GO:0050932) | 2.33451561 |
| 158 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.32905743 |
| 159 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 2.32843151 |
| 160 | piRNA metabolic process (GO:0034587) | 2.32630353 |
| 161 | response to type I interferon (GO:0034340) | 2.32607505 |
| 162 | detection of mechanical stimulus involved in sensory perception (GO:0050974) | 2.32100637 |
| 163 | negative regulation of granulocyte differentiation (GO:0030853) | 2.31769593 |
| 164 | positive regulation of CREB transcription factor activity (GO:0032793) | 2.31591581 |
| 165 | photoreceptor cell development (GO:0042461) | 2.31457956 |
| 166 | positive regulation of phosphatase activity (GO:0010922) | 2.31120986 |
| 167 | regulation of neurotransmitter uptake (GO:0051580) | 2.29937949 |
| 168 | opioid receptor signaling pathway (GO:0038003) | 2.29921692 |
| 169 | negative regulation of keratinocyte proliferation (GO:0010839) | 2.29588876 |
| 170 | NAD biosynthetic process (GO:0009435) | 2.28866120 |
| 171 | negative regulation of Rho protein signal transduction (GO:0035024) | 2.28522262 |
| 172 | regulation of male gonad development (GO:2000018) | 2.28491511 |
| 173 | histone H3-K9 methylation (GO:0051567) | 2.28275111 |
| 174 | cilium organization (GO:0044782) | 2.28142409 |
| 175 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.28083924 |
| 176 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.27967313 |
| 177 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.27927760 |
| 178 | cellular response to type I interferon (GO:0071357) | 2.27459033 |
| 179 | type I interferon signaling pathway (GO:0060337) | 2.27459033 |
| 180 | positive regulation of smooth muscle cell migration (GO:0014911) | 2.26956682 |
| 181 | DNA integration (GO:0015074) | 2.26954240 |
| 182 | peristalsis (GO:0030432) | 2.26221329 |
| 183 | sphingoid metabolic process (GO:0046519) | 2.25243006 |
| 184 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.25130632 |
| 185 | response to host (GO:0075136) | 2.25130632 |
| 186 | response to host defenses (GO:0052200) | 2.25130632 |
| 187 | dopamine transport (GO:0015872) | 2.25010055 |
| 188 | cAMP catabolic process (GO:0006198) | 2.24734343 |
| 189 | glycosphingolipid catabolic process (GO:0046479) | 2.22704549 |
| 190 | lipoxygenase pathway (GO:0019372) | 2.22429352 |
| 191 | negative regulation of leukocyte chemotaxis (GO:0002689) | 2.22345650 |
| 192 | motile cilium assembly (GO:0044458) | 2.21940237 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.10279705 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.95396196 |
| 3 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.19771059 |
| 4 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.88219778 |
| 5 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.68573113 |
| 6 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.64264894 |
| 7 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.58372807 |
| 8 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.56794608 |
| 9 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 2.42619923 |
| 10 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.17093690 |
| 11 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 2.15761247 |
| 12 | FUS_26573619_Chip-Seq_HEK293_Human | 2.15448415 |
| 13 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.10961755 |
| 14 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.10770869 |
| 15 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 2.05962566 |
| 16 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.05492682 |
| 17 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.03347051 |
| 18 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 2.02173114 |
| 19 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.92787086 |
| 20 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.90874187 |
| 21 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.88844293 |
| 22 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.86274052 |
| 23 | EWS_26573619_Chip-Seq_HEK293_Human | 1.86200527 |
| 24 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.85498378 |
| 25 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.82842923 |
| 26 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.80330375 |
| 27 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.79750538 |
| 28 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.78808506 |
| 29 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.78067559 |
| 30 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.74860481 |
| 31 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.74533873 |
| 32 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.72177525 |
| 33 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.71872540 |
| 34 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.70456026 |
| 35 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.69515931 |
| 36 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.66031414 |
| 37 | P300_19829295_ChIP-Seq_ESCs_Human | 1.64505555 |
| 38 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.64397690 |
| 39 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.63912585 |
| 40 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.63823016 |
| 41 | AR_25329375_ChIP-Seq_VCAP_Human | 1.62335294 |
| 42 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 1.60050541 |
| 43 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.59583623 |
| 44 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.58386213 |
| 45 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.58274504 |
| 46 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.58168241 |
| 47 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.58139737 |
| 48 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.57394650 |
| 49 | PU1_27457419_Chip-Seq_LIVER_Mouse | 1.57195556 |
| 50 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.56881266 |
| 51 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.56862014 |
| 52 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.56750300 |
| 53 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.56081461 |
| 54 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.54820109 |
| 55 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.52638940 |
| 56 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.52589377 |
| 57 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.50822487 |
| 58 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.50361595 |
| 59 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.49275828 |
| 60 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.47955730 |
| 61 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 1.46723268 |
| 62 | TP53_16413492_ChIP-PET_HCT116_Human | 1.45996972 |
| 63 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.44791791 |
| 64 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.44791791 |
| 65 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.40483699 |
| 66 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.40453571 |
| 67 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.40279881 |
| 68 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.40048730 |
| 69 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.40038897 |
| 70 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.39927314 |
| 71 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.39174738 |
| 72 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.38774639 |
| 73 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.38404666 |
| 74 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 1.38209604 |
| 75 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.35697327 |
| 76 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.35213763 |
| 77 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 1.34297919 |
| 78 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.32906378 |
| 79 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.32260188 |
| 80 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 1.31722315 |
| 81 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.31355216 |
| 82 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.30746761 |
| 83 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.30700752 |
| 84 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.30408692 |
| 85 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.29632017 |
| 86 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.29042305 |
| 87 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.29042305 |
| 88 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.28667593 |
| 89 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.28224600 |
| 90 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.27994235 |
| 91 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.27549169 |
| 92 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.27264304 |
| 93 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.26894656 |
| 94 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.26678199 |
| 95 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.26616052 |
| 96 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.26616052 |
| 97 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.26517584 |
| 98 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.26133986 |
| 99 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.25905170 |
| 100 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.24415465 |
| 101 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.23732198 |
| 102 | * MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.23432913 |
| 103 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21549699 |
| 104 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.21446729 |
| 105 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.21229680 |
| 106 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.21229680 |
| 107 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.19804060 |
| 108 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.19354958 |
| 109 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.19281292 |
| 110 | KDM2B_26808549_Chip-Seq_REH_Human | 1.19200876 |
| 111 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.17767070 |
| 112 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.17495405 |
| 113 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.16879514 |
| 114 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.16421044 |
| 115 | STAT3_23295773_ChIP-Seq_U87_Human | 1.16309694 |
| 116 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.14833562 |
| 117 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.13788104 |
| 118 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.13645862 |
| 119 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.13499488 |
| 120 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.12946370 |
| 121 | VDR_22108803_ChIP-Seq_LS180_Human | 1.12738901 |
| 122 | TCF4_23295773_ChIP-Seq_U87_Human | 1.12032953 |
| 123 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.11858075 |
| 124 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.11191394 |
| 125 | RXR_22108803_ChIP-Seq_LS180_Human | 1.11191336 |
| 126 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.10829490 |
| 127 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.10283980 |
| 128 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.09336474 |
| 129 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.09247077 |
| 130 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.08759097 |
| 131 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.08432654 |
| 132 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.08169138 |
| 133 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.07862174 |
| 134 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.07670598 |
| 135 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.06314445 |
| 136 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.06124300 |
| 137 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.06114469 |
| 138 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.06114469 |
| 139 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.05528099 |
| 140 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.05520502 |
| 141 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.04143000 |
| 142 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.04000364 |
| 143 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.03792737 |
| 144 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.03586934 |
| 145 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.01156410 |
| 146 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.01063644 |
| 147 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.00429778 |
| 148 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.99914269 |
| 149 | GATA1_22025678_ChIP-Seq_K562_Human | 0.99087086 |
| 150 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.98511864 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 4.35567135 |
| 2 | MP0000566_synostosis | 3.91243989 |
| 3 | MP0001188_hyperpigmentation | 3.65475479 |
| 4 | MP0008004_abnormal_stomach_pH | 3.33546191 |
| 5 | MP0010368_abnormal_lymphatic_system | 3.21902595 |
| 6 | MP0000569_abnormal_digit_pigmentation | 3.11247562 |
| 7 | MP0001879_abnormal_lymphatic_vessel | 3.01986412 |
| 8 | MP0001968_abnormal_touch/_nociception | 2.91660859 |
| 9 | MP0005171_absent_coat_pigmentation | 2.82168805 |
| 10 | MP0005409_darkened_coat_color | 2.69419458 |
| 11 | MP0006292_abnormal_olfactory_placode | 2.67841264 |
| 12 | MP0002277_abnormal_respiratory_mucosa | 2.62981749 |
| 13 | MP0009697_abnormal_copulation | 2.45777438 |
| 14 | MP0002148_abnormal_hypersensitivity_rea | 2.40112505 |
| 15 | MP0003136_yellow_coat_color | 2.31091256 |
| 16 | MP0002837_dystrophic_cardiac_calcinosis | 2.28814696 |
| 17 | MP0008872_abnormal_physiological_respon | 2.25983787 |
| 18 | MP0005645_abnormal_hypothalamus_physiol | 2.15741310 |
| 19 | MP0001501_abnormal_sleep_pattern | 2.13683003 |
| 20 | MP0009046_muscle_twitch | 2.11461072 |
| 21 | MP0001986_abnormal_taste_sensitivity | 2.06892635 |
| 22 | MP0010386_abnormal_urinary_bladder | 2.06324241 |
| 23 | MP0002138_abnormal_hepatobiliary_system | 2.05507773 |
| 24 | MP0002736_abnormal_nociception_after | 2.04955621 |
| 25 | MP0003941_abnormal_skin_development | 2.01858987 |
| 26 | MP0005174_abnormal_tail_pigmentation | 2.01530633 |
| 27 | MP0009745_abnormal_behavioral_response | 1.99833425 |
| 28 | MP0008995_early_reproductive_senescence | 1.98574180 |
| 29 | MP0004782_abnormal_surfactant_physiolog | 1.98301510 |
| 30 | MP0009780_abnormal_chondrocyte_physiolo | 1.96252868 |
| 31 | MP0002876_abnormal_thyroid_physiology | 1.95655055 |
| 32 | MP0004215_abnormal_myocardial_fiber | 1.92323421 |
| 33 | MP0008875_abnormal_xenobiotic_pharmacok | 1.89152886 |
| 34 | MP0003950_abnormal_plasma_membrane | 1.84795726 |
| 35 | MP0005646_abnormal_pituitary_gland | 1.84075094 |
| 36 | MP0001835_abnormal_antigen_presentation | 1.83194069 |
| 37 | MP0002638_abnormal_pupillary_reflex | 1.82445154 |
| 38 | MP0004043_abnormal_pH_regulation | 1.80361920 |
| 39 | MP0003787_abnormal_imprinting | 1.80361090 |
| 40 | MP0008775_abnormal_heart_ventricle | 1.79523176 |
| 41 | MP0000678_abnormal_parathyroid_gland | 1.79445741 |
| 42 | MP0000427_abnormal_hair_cycle | 1.79360353 |
| 43 | MP0008877_abnormal_DNA_methylation | 1.72820284 |
| 44 | MP0003646_muscle_fatigue | 1.72501736 |
| 45 | MP0009764_decreased_sensitivity_to | 1.71921847 |
| 46 | MP0000015_abnormal_ear_pigmentation | 1.70003268 |
| 47 | MP0002272_abnormal_nervous_system | 1.68362981 |
| 48 | MP0004084_abnormal_cardiac_muscle | 1.67555468 |
| 49 | MP0005670_abnormal_white_adipose | 1.63583321 |
| 50 | MP0006072_abnormal_retinal_apoptosis | 1.63208542 |
| 51 | MP0001485_abnormal_pinna_reflex | 1.59586493 |
| 52 | MP0001502_abnormal_circadian_rhythm | 1.52329103 |
| 53 | MP0002132_abnormal_respiratory_system | 1.51391510 |
| 54 | MP0000383_abnormal_hair_follicle | 1.51149255 |
| 55 | MP0009785_altered_susceptibility_to | 1.48655380 |
| 56 | MP0004145_abnormal_muscle_electrophysio | 1.47026100 |
| 57 | MP0002572_abnormal_emotion/affect_behav | 1.45256774 |
| 58 | MP0006276_abnormal_autonomic_nervous | 1.43881526 |
| 59 | MP0004885_abnormal_endolymph | 1.43519686 |
| 60 | MP0001790_abnormal_immune_system | 1.39296507 |
| 61 | MP0005387_immune_system_phenotype | 1.39296507 |
| 62 | MP0003195_calcinosis | 1.38049789 |
| 63 | MP0000230_abnormal_systemic_arterial | 1.36694839 |
| 64 | MP0004085_abnormal_heartbeat | 1.35000106 |
| 65 | MP0002733_abnormal_thermal_nociception | 1.33768725 |
| 66 | MP0002102_abnormal_ear_morphology | 1.31971411 |
| 67 | MP0005084_abnormal_gallbladder_morpholo | 1.31180018 |
| 68 | MP0002064_seizures | 1.30209695 |
| 69 | MP0004742_abnormal_vestibular_system | 1.29715958 |
| 70 | MP0003137_abnormal_impulse_conducting | 1.27375080 |
| 71 | MP0002419_abnormal_innate_immunity | 1.26141790 |
| 72 | MP0003868_abnormal_feces_composition | 1.25957185 |
| 73 | MP0003635_abnormal_synaptic_transmissio | 1.25547555 |
| 74 | MP0002557_abnormal_social/conspecific_i | 1.24988222 |
| 75 | MP0000372_irregular_coat_pigmentation | 1.23449791 |
| 76 | MP0005671_abnormal_response_to | 1.23236320 |
| 77 | MP0000631_abnormal_neuroendocrine_gland | 1.22835073 |
| 78 | MP0004484_altered_response_of | 1.22489633 |
| 79 | MP0005167_abnormal_blood-brain_barrier | 1.21564020 |
| 80 | MP0001970_abnormal_pain_threshold | 1.21225400 |
| 81 | MP0004924_abnormal_behavior | 1.19026416 |
| 82 | MP0005386_behavior/neurological_phenoty | 1.19026416 |
| 83 | MP0001851_eye_inflammation | 1.18251265 |
| 84 | MP0002063_abnormal_learning/memory/cond | 1.17625319 |
| 85 | MP0003828_pulmonary_edema | 1.16640014 |
| 86 | MP0002653_abnormal_ependyma_morphology | 1.15639408 |
| 87 | MP0002067_abnormal_sensory_capabilities | 1.15611680 |
| 88 | MP0002928_abnormal_bile_duct | 1.15087353 |
| 89 | MP0000681_abnormal_thyroid_gland | 1.14321609 |
| 90 | MP0008058_abnormal_DNA_repair | 1.12674783 |
| 91 | MP0003045_fibrosis | 1.12553054 |
| 92 | MP0004130_abnormal_muscle_cell | 1.12504603 |
| 93 | MP0009384_cardiac_valve_regurgitation | 1.10161858 |
| 94 | MP0008260_abnormal_autophagy | 1.09523924 |
| 95 | MP0005647_abnormal_sex_gland | 1.06199739 |
| 96 | MP0004019_abnormal_vitamin_homeostasis | 1.05791649 |
| 97 | MP0010155_abnormal_intestine_physiology | 1.05064490 |
| 98 | MP0001984_abnormal_olfaction | 1.04687755 |
| 99 | MP0005310_abnormal_salivary_gland | 0.99703865 |
| 100 | MP0005551_abnormal_eye_electrophysiolog | 0.99700346 |
| 101 | MP0003880_abnormal_central_pattern | 0.99683807 |
| 102 | MP0002735_abnormal_chemical_nociception | 0.98234792 |
| 103 | MP0005025_abnormal_response_to | 0.97974224 |
| 104 | MP0005379_endocrine/exocrine_gland_phen | 0.97249503 |
| 105 | MP0002693_abnormal_pancreas_physiology | 0.96250546 |
| 106 | MP0004036_abnormal_muscle_relaxation | 0.95298136 |
| 107 | MP0004147_increased_porphyrin_level | 0.94155800 |
| 108 | MP0005195_abnormal_posterior_eye | 0.93612552 |
| 109 | MP0002938_white_spotting | 0.93427954 |
| 110 | MP0005000_abnormal_immune_tolerance | 0.92010502 |
| 111 | MP0005253_abnormal_eye_physiology | 0.89689365 |
| 112 | MP0010329_abnormal_lipoprotein_level | 0.89402283 |
| 113 | MP0002734_abnormal_mechanical_nocicepti | 0.89008077 |
| 114 | MP0004133_heterotaxia | 0.86297189 |
| 115 | MP0005503_abnormal_tendon_morphology | 0.86282250 |
| 116 | MP0001664_abnormal_digestion | 0.86005415 |
| 117 | MP0001756_abnormal_urination | 0.85468696 |
| 118 | MP0000026_abnormal_inner_ear | 0.85311146 |
| 119 | MP0002184_abnormal_innervation | 0.83933659 |
| 120 | MP0001440_abnormal_grooming_behavior | 0.83832599 |
| 121 | MP0002229_neurodegeneration | 0.83499094 |
| 122 | MP0006054_spinal_hemorrhage | 0.83252486 |
| 123 | MP0000613_abnormal_salivary_gland | 0.82258298 |
| 124 | MP0001186_pigmentation_phenotype | 0.82077991 |
| 125 | MP0002998_abnormal_bone_remodeling | 0.81277170 |
| 126 | MP0003011_delayed_dark_adaptation | 0.80759076 |
| 127 | MP0003878_abnormal_ear_physiology | 0.80715747 |
| 128 | MP0005377_hearing/vestibular/ear_phenot | 0.80715747 |
| 129 | MP0000778_abnormal_nervous_system | 0.80631892 |
| 130 | MP0006138_congestive_heart_failure | 0.79031103 |
| 131 | MP0001486_abnormal_startle_reflex | 0.78474485 |
| 132 | MP0001800_abnormal_humoral_immune | 0.77896192 |
| 133 | MP0002009_preneoplasia | 0.77850846 |
| 134 | MP0004381_abnormal_hair_follicle | 0.77848714 |
| 135 | MP0002723_abnormal_immune_serum | 0.77787284 |
| 136 | MP0000639_abnormal_adrenal_gland | 0.77728204 |
| 137 | MP0002127_abnormal_cardiovascular_syste | 0.77676174 |
| 138 | MP0003252_abnormal_bile_duct | 0.77515268 |
| 139 | MP0010678_abnormal_skin_adnexa | 0.77162856 |
| 140 | MP0000013_abnormal_adipose_tissue | 0.76947425 |
| 141 | MP0005075_abnormal_melanosome_morpholog | 0.76409408 |
| 142 | MP0005620_abnormal_muscle_contractility | 0.75500707 |
| 143 | MP0002452_abnormal_antigen_presenting | 0.75231493 |
| 144 | MP0002752_abnormal_somatic_nervous | 0.74857972 |
| 145 | MP0005165_increased_susceptibility_to | 0.74425779 |
| 146 | MP0008057_abnormal_DNA_replication | 0.74079419 |
| 147 | MP0000371_diluted_coat_color | 0.73766765 |
| 148 | MP0005410_abnormal_fertilization | 0.72248600 |
| 149 | MP0003937_abnormal_limbs/digits/tail_de | 0.72239392 |
| 150 | MP0005595_abnormal_vascular_smooth | 0.72232659 |
| 151 | MP0001873_stomach_inflammation | 0.70306594 |
| 152 | MP0000343_altered_response_to | 0.69491466 |
| 153 | MP0005220_abnormal_exocrine_pancreas | 0.69251812 |
| 154 | MP0004142_abnormal_muscle_tone | 0.67886990 |
| 155 | MP0002163_abnormal_gland_morphology | 0.67872564 |
| 156 | MP0000470_abnormal_stomach_morphology | 0.67505526 |
| 157 | MP0005367_renal/urinary_system_phenotyp | 0.67367594 |
| 158 | MP0000516_abnormal_urinary_system | 0.67367594 |
| 159 | MP0001119_abnormal_female_reproductive | 0.67032936 |
| 160 | MP0001346_abnormal_lacrimal_gland | 0.66755687 |
| 161 | MP0001819_abnormal_immune_cell | 0.66314371 |
| 162 | MP0001963_abnormal_hearing_physiology | 0.66043315 |
| 163 | MP0003879_abnormal_hair_cell | 0.64430935 |
| 164 | MP0002420_abnormal_adaptive_immunity | 0.63935179 |
| 165 | MP0001270_distended_abdomen | 0.62347363 |
| 166 | MP0001845_abnormal_inflammatory_respons | 0.61921391 |
| 167 | MP0000490_abnormal_crypts_of | 0.61231802 |
| 168 | MP0002168_other_aberrant_phenotype | 0.59908022 |
| 169 | MP0002095_abnormal_skin_pigmentation | 0.59823795 |
| 170 | MP0005390_skeleton_phenotype | 0.58242677 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 5.02124593 |
| 2 | Hyperventilation (HP:0002883) | 4.30974045 |
| 3 | Pancreatic fibrosis (HP:0100732) | 4.22694878 |
| 4 | Abnormality of midbrain morphology (HP:0002418) | 4.09821666 |
| 5 | Molar tooth sign on MRI (HP:0002419) | 4.09821666 |
| 6 | Chromsome breakage (HP:0040012) | 4.00732937 |
| 7 | Genetic anticipation (HP:0003743) | 3.89777543 |
| 8 | Chronic hepatic failure (HP:0100626) | 3.75146307 |
| 9 | Nephronophthisis (HP:0000090) | 3.65288271 |
| 10 | Duplicated collecting system (HP:0000081) | 3.61562335 |
| 11 | Medial flaring of the eyebrow (HP:0010747) | 3.43018046 |
| 12 | Osteomalacia (HP:0002749) | 3.35522663 |
| 13 | Abnormality of the renal medulla (HP:0100957) | 3.34911393 |
| 14 | Abnormality of the renal collecting system (HP:0004742) | 3.30113005 |
| 15 | Progressive cerebellar ataxia (HP:0002073) | 3.24032978 |
| 16 | Prostate neoplasm (HP:0100787) | 3.23258493 |
| 17 | Abnormality of alanine metabolism (HP:0010916) | 3.10649052 |
| 18 | Hyperalaninemia (HP:0003348) | 3.10649052 |
| 19 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 3.10649052 |
| 20 | Gaze-evoked nystagmus (HP:0000640) | 3.10049936 |
| 21 | Renal cortical cysts (HP:0000803) | 3.08232836 |
| 22 | Febrile seizures (HP:0002373) | 3.07903532 |
| 23 | Congenital sensorineural hearing impairment (HP:0008527) | 3.06272557 |
| 24 | Alveolar cell carcinoma (HP:0006519) | 3.04793962 |
| 25 | Attenuation of retinal blood vessels (HP:0007843) | 3.00385443 |
| 26 | Cystic liver disease (HP:0006706) | 3.00089761 |
| 27 | Abolished electroretinogram (ERG) (HP:0000550) | 2.98232068 |
| 28 | Large for gestational age (HP:0001520) | 2.95418037 |
| 29 | Tubular atrophy (HP:0000092) | 2.85162234 |
| 30 | Hypothermia (HP:0002045) | 2.84515139 |
| 31 | Absent eyebrow (HP:0002223) | 2.80613442 |
| 32 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.74655899 |
| 33 | Hypoplasia of the fovea (HP:0007750) | 2.74391260 |
| 34 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.74391260 |
| 35 | Hypergonadotropic hypogonadism (HP:0000815) | 2.74140195 |
| 36 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.74043995 |
| 37 | Absent/shortened dynein arms (HP:0200106) | 2.74043995 |
| 38 | Abnormal ciliary motility (HP:0012262) | 2.71955672 |
| 39 | Gait imbalance (HP:0002141) | 2.67772643 |
| 40 | True hermaphroditism (HP:0010459) | 2.67626657 |
| 41 | Pendular nystagmus (HP:0012043) | 2.66711752 |
| 42 | Congenital stationary night blindness (HP:0007642) | 2.65220335 |
| 43 | Genital tract atresia (HP:0001827) | 2.64322012 |
| 44 | Hyperphosphatemia (HP:0002905) | 2.59223495 |
| 45 | Inability to walk (HP:0002540) | 2.59110510 |
| 46 | Type II lissencephaly (HP:0007260) | 2.58111605 |
| 47 | Abnormal drinking behavior (HP:0030082) | 2.56774060 |
| 48 | Polydipsia (HP:0001959) | 2.56774060 |
| 49 | Congenital primary aphakia (HP:0007707) | 2.55842671 |
| 50 | Tachypnea (HP:0002789) | 2.52579373 |
| 51 | Stomach cancer (HP:0012126) | 2.50377101 |
| 52 | Bile duct proliferation (HP:0001408) | 2.46175606 |
| 53 | Abnormal biliary tract physiology (HP:0012439) | 2.46175606 |
| 54 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.45482901 |
| 55 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.45482901 |
| 56 | Hemiparesis (HP:0001269) | 2.44891047 |
| 57 | Septo-optic dysplasia (HP:0100842) | 2.41369085 |
| 58 | Vaginal atresia (HP:0000148) | 2.41114395 |
| 59 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.36515959 |
| 60 | Broad-based gait (HP:0002136) | 2.34795025 |
| 61 | Patchy hypopigmentation of hair (HP:0011365) | 2.34313804 |
| 62 | Abnormality of DNA repair (HP:0003254) | 2.32779896 |
| 63 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.32069625 |
| 64 | Nephrogenic diabetes insipidus (HP:0009806) | 2.31393173 |
| 65 | Tubulointerstitial nephritis (HP:0001970) | 2.30947020 |
| 66 | White forelock (HP:0002211) | 2.30424512 |
| 67 | Unilateral renal agenesis (HP:0000122) | 2.30400722 |
| 68 | Aplasia cutis congenita (HP:0001057) | 2.29357794 |
| 69 | Decreased central vision (HP:0007663) | 2.27865039 |
| 70 | Intestinal atresia (HP:0011100) | 2.27312567 |
| 71 | Furrowed tongue (HP:0000221) | 2.25914190 |
| 72 | Keratoconus (HP:0000563) | 2.25325965 |
| 73 | Increased corneal curvature (HP:0100692) | 2.25325965 |
| 74 | Focal seizures (HP:0007359) | 2.25273431 |
| 75 | Widely spaced teeth (HP:0000687) | 2.24082434 |
| 76 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.22210241 |
| 77 | Decreased circulating renin level (HP:0003351) | 2.21132628 |
| 78 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.20254927 |
| 79 | Abnormality of the dental pulp (HP:0006479) | 2.19641349 |
| 80 | Retrobulbar optic neuritis (HP:0100654) | 2.18408744 |
| 81 | Optic neuritis (HP:0100653) | 2.18408744 |
| 82 | Clumsiness (HP:0002312) | 2.17689000 |
| 83 | Sclerocornea (HP:0000647) | 2.16963499 |
| 84 | Clubbing of toes (HP:0100760) | 2.16919526 |
| 85 | Abnormality of the fovea (HP:0000493) | 2.16910284 |
| 86 | Progressive inability to walk (HP:0002505) | 2.15815651 |
| 87 | Abnormality of the renal cortex (HP:0011035) | 2.15702431 |
| 88 | Chorioretinal atrophy (HP:0000533) | 2.15377890 |
| 89 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.14965272 |
| 90 | Ectopic kidney (HP:0000086) | 2.14401252 |
| 91 | Type I transferrin isoform profile (HP:0003642) | 2.14242852 |
| 92 | Conical tooth (HP:0000698) | 2.12031170 |
| 93 | Joint hemorrhage (HP:0005261) | 2.10728580 |
| 94 | Abnormality of incisor morphology (HP:0011063) | 2.10724521 |
| 95 | Submucous cleft hard palate (HP:0000176) | 2.10695039 |
| 96 | Thyroiditis (HP:0100646) | 2.10646672 |
| 97 | Cheilitis (HP:0100825) | 2.09827670 |
| 98 | Lip pit (HP:0100267) | 2.09724752 |
| 99 | Absent speech (HP:0001344) | 2.07971084 |
| 100 | Cerebellar dysplasia (HP:0007033) | 2.07274070 |
| 101 | Fair hair (HP:0002286) | 2.06425818 |
| 102 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.05749044 |
| 103 | Symptomatic seizures (HP:0011145) | 2.05081935 |
| 104 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.03649664 |
| 105 | Polyuria (HP:0000103) | 2.03410312 |
| 106 | Hypoplastic iliac wings (HP:0002866) | 2.02979804 |
| 107 | Abnormal hair whorl (HP:0010721) | 2.02122875 |
| 108 | Abnormality of B cell number (HP:0010975) | 2.01595419 |
| 109 | Median cleft lip (HP:0000161) | 2.01505172 |
| 110 | Optic nerve hypoplasia (HP:0000609) | 2.00448970 |
| 111 | Abnormality of molar (HP:0011077) | 1.98519266 |
| 112 | Abnormality of molar morphology (HP:0011070) | 1.98519266 |
| 113 | Abnormality of renal resorption (HP:0011038) | 1.98195517 |
| 114 | Recurrent abscess formation (HP:0002722) | 1.97769199 |
| 115 | Recurrent pneumonia (HP:0006532) | 1.97645731 |
| 116 | Tetany (HP:0001281) | 1.97512077 |
| 117 | Portal hypertension (HP:0001409) | 1.96221791 |
| 118 | Abnormality of the hepatic vasculature (HP:0006707) | 1.95191281 |
| 119 | Epileptic encephalopathy (HP:0200134) | 1.95041091 |
| 120 | Amelogenesis imperfecta (HP:0000705) | 1.95028680 |
| 121 | Poor coordination (HP:0002370) | 1.93152292 |
| 122 | Morphological abnormality of the middle ear (HP:0008609) | 1.90739705 |
| 123 | Tubulointerstitial fibrosis (HP:0005576) | 1.89292868 |
| 124 | Postaxial foot polydactyly (HP:0001830) | 1.89245169 |
| 125 | Abnormality of the pons (HP:0007361) | 1.89234148 |
| 126 | Ketoacidosis (HP:0001993) | 1.88880541 |
| 127 | Vascular calcification (HP:0004934) | 1.87923386 |
| 128 | Reduced antithrombin III activity (HP:0001976) | 1.87862668 |
| 129 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.87613371 |
| 130 | Short foot (HP:0001773) | 1.87550940 |
| 131 | Hypoproteinemia (HP:0003075) | 1.86904922 |
| 132 | Orchitis (HP:0100796) | 1.86810138 |
| 133 | Generalized hypopigmentation of hair (HP:0011358) | 1.86460967 |
| 134 | Bulbous nose (HP:0000414) | 1.84583161 |
| 135 | Parakeratosis (HP:0001036) | 1.84161024 |
| 136 | Pulmonary artery stenosis (HP:0004415) | 1.83640218 |
| 137 | Protruding tongue (HP:0010808) | 1.83374906 |
| 138 | Congenital hepatic fibrosis (HP:0002612) | 1.82515151 |
| 139 | Severe visual impairment (HP:0001141) | 1.82152475 |
| 140 | Nonimmune hydrops fetalis (HP:0001790) | 1.82041163 |
| 141 | Pancreatic cysts (HP:0001737) | 1.81927468 |
| 142 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.80467108 |
| 143 | Distal lower limb muscle weakness (HP:0009053) | 1.80299787 |
| 144 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.78901009 |
| 145 | Metaphyseal dysplasia (HP:0100255) | 1.77684123 |
| 146 | Lissencephaly (HP:0001339) | 1.77570167 |
| 147 | Hypoplastic ischia (HP:0003175) | 1.77537463 |
| 148 | Upper limb muscle weakness (HP:0003484) | 1.77449460 |
| 149 | Capillary hemangiomas (HP:0005306) | 1.76493035 |
| 150 | Ectropion (HP:0000656) | 1.76073160 |
| 151 | Tubulointerstitial abnormality (HP:0001969) | 1.75995123 |
| 152 | Postaxial hand polydactyly (HP:0001162) | 1.75452620 |
| 153 | Anencephaly (HP:0002323) | 1.75381798 |
| 154 | Palpebral edema (HP:0100540) | 1.74736365 |
| 155 | Abnormality of homocysteine metabolism (HP:0010919) | 1.74535807 |
| 156 | Homocystinuria (HP:0002156) | 1.74535807 |
| 157 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.74406762 |
| 158 | B lymphocytopenia (HP:0010976) | 1.74383472 |
| 159 | Atonic seizures (HP:0010819) | 1.73956239 |
| 160 | Spontaneous hematomas (HP:0007420) | 1.73526347 |
| 161 | Male pseudohermaphroditism (HP:0000037) | 1.72451498 |
| 162 | Abnormality of the ischium (HP:0003174) | 1.72221137 |
| 163 | Hypoplasia of the iris (HP:0007676) | 1.72211991 |
| 164 | Drooling (HP:0002307) | 1.71785384 |
| 165 | Abnormality of the prostate (HP:0008775) | 1.71266348 |
| 166 | Conjugated hyperbilirubinemia (HP:0002908) | 1.70821453 |
| 167 | Gingivitis (HP:0000230) | 1.70617700 |
| 168 | Left ventricular hypertrophy (HP:0001712) | 1.70427163 |
| 169 | Adactyly (HP:0009776) | 1.70214556 |
| 170 | Severe muscular hypotonia (HP:0006829) | 1.70190427 |
| 171 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.69945535 |
| 172 | Neoplasm of the lung (HP:0100526) | 1.69809247 |
| 173 | Ketosis (HP:0001946) | 1.69348391 |
| 174 | Abnormality of the pubic bones (HP:0003172) | 1.69135936 |
| 175 | Type 2 muscle fiber atrophy (HP:0003554) | 1.69082756 |
| 176 | Abnormality of the preputium (HP:0100587) | 1.69062322 |
| 177 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.67898750 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TIE1 | 4.65576753 |
| 2 | ZAK | 3.75182341 |
| 3 | KDR | 3.33600564 |
| 4 | IRAK3 | 3.16716407 |
| 5 | CASK | 2.80465694 |
| 6 | MAP3K14 | 2.68575231 |
| 7 | SIK3 | 2.31985028 |
| 8 | INSRR | 2.25614336 |
| 9 | MAP4K2 | 2.25188604 |
| 10 | AKT3 | 2.23187260 |
| 11 | TAOK3 | 2.22956827 |
| 12 | IRAK4 | 2.11982785 |
| 13 | TXK | 2.11021871 |
| 14 | GRK1 | 2.06317575 |
| 15 | WNK4 | 1.94137905 |
| 16 | BRSK2 | 1.91252948 |
| 17 | ACVR1B | 1.88873388 |
| 18 | EIF2AK2 | 1.87803493 |
| 19 | WNK3 | 1.84299302 |
| 20 | TGFBR2 | 1.80246545 |
| 21 | SGK2 | 1.78444872 |
| 22 | PRPF4B | 1.76366344 |
| 23 | STK16 | 1.74861732 |
| 24 | TNIK | 1.73219629 |
| 25 | STK39 | 1.57802251 |
| 26 | MAPK15 | 1.55841863 |
| 27 | BMPR2 | 1.52230665 |
| 28 | IKBKE | 1.49973637 |
| 29 | TEC | 1.48293294 |
| 30 | MAP3K4 | 1.43548056 |
| 31 | OXSR1 | 1.42502887 |
| 32 | PAK3 | 1.42219811 |
| 33 | ADRBK2 | 1.41914451 |
| 34 | YES1 | 1.40150460 |
| 35 | NEK6 | 1.33386405 |
| 36 | CAMKK2 | 1.28344611 |
| 37 | BRD4 | 1.26182875 |
| 38 | ADRBK1 | 1.17776754 |
| 39 | MAPK13 | 1.16814863 |
| 40 | MAP2K7 | 1.14724546 |
| 41 | GRK7 | 1.14249044 |
| 42 | SGK223 | 1.12410653 |
| 43 | SGK494 | 1.12410653 |
| 44 | FGFR2 | 1.12039273 |
| 45 | STK38L | 1.11855356 |
| 46 | MARK1 | 1.11554612 |
| 47 | PTK2B | 1.11445033 |
| 48 | ERBB3 | 1.07933825 |
| 49 | PLK4 | 1.07207824 |
| 50 | BMPR1B | 1.07135852 |
| 51 | SGK3 | 1.05846662 |
| 52 | CDK3 | 1.05400707 |
| 53 | CSNK1A1L | 1.02820861 |
| 54 | IKBKB | 1.02372426 |
| 55 | NUAK1 | 0.99439071 |
| 56 | TAOK2 | 0.98476146 |
| 57 | BCR | 0.96486033 |
| 58 | JAK1 | 0.95271715 |
| 59 | PBK | 0.94783892 |
| 60 | PIK3CG | 0.94386860 |
| 61 | CHUK | 0.89719473 |
| 62 | MAP3K7 | 0.89485325 |
| 63 | PRKCG | 0.88318432 |
| 64 | CDK8 | 0.87388139 |
| 65 | PINK1 | 0.87235826 |
| 66 | JAK3 | 0.84937487 |
| 67 | CLK1 | 0.84555096 |
| 68 | MUSK | 0.83282698 |
| 69 | TGFBR1 | 0.82712929 |
| 70 | NEK9 | 0.82544740 |
| 71 | CAMK1 | 0.82510579 |
| 72 | CSNK1G1 | 0.81144281 |
| 73 | EPHA4 | 0.81003047 |
| 74 | FER | 0.80713463 |
| 75 | BLK | 0.78011543 |
| 76 | PIK3CA | 0.76024098 |
| 77 | STK3 | 0.74837935 |
| 78 | EPHA2 | 0.74441936 |
| 79 | FRK | 0.74159111 |
| 80 | MAPK7 | 0.73503933 |
| 81 | EPHB2 | 0.72143589 |
| 82 | ITK | 0.71921574 |
| 83 | LATS1 | 0.71111255 |
| 84 | MKNK2 | 0.70551879 |
| 85 | OBSCN | 0.69783026 |
| 86 | EPHA3 | 0.69343607 |
| 87 | TNK2 | 0.66570606 |
| 88 | TRPM7 | 0.66017805 |
| 89 | IRAK1 | 0.65510223 |
| 90 | CSNK1G2 | 0.65477545 |
| 91 | BTK | 0.62813821 |
| 92 | PRKCE | 0.59016249 |
| 93 | CSNK1G3 | 0.58781216 |
| 94 | TRIM28 | 0.58382154 |
| 95 | BCKDK | 0.55747653 |
| 96 | STK38 | 0.55674308 |
| 97 | MAPKAPK3 | 0.53492876 |
| 98 | NLK | 0.53067529 |
| 99 | TLK1 | 0.52860305 |
| 100 | PRKAA1 | 0.52274883 |
| 101 | LYN | 0.52217000 |
| 102 | DAPK2 | 0.51287263 |
| 103 | MYLK | 0.51189958 |
| 104 | NTRK3 | 0.50777027 |
| 105 | SGK1 | 0.49856874 |
| 106 | DYRK1A | 0.49720099 |
| 107 | STK11 | 0.48658387 |
| 108 | GRK5 | 0.48011013 |
| 109 | CAMK4 | 0.47545272 |
| 110 | MST4 | 0.47296083 |
| 111 | MAPK11 | 0.46964364 |
| 112 | CDK12 | 0.46650734 |
| 113 | TYK2 | 0.46094000 |
| 114 | MAPK12 | 0.44482480 |
| 115 | IRAK2 | 0.44251757 |
| 116 | CAMK1D | 0.44212148 |
| 117 | WNK1 | 0.44116537 |
| 118 | PRKCI | 0.43882642 |
| 119 | LIMK1 | 0.43844154 |
| 120 | HCK | 0.43150102 |
| 121 | TBK1 | 0.42203071 |
| 122 | KIT | 0.42058545 |
| 123 | PKN1 | 0.41493953 |
| 124 | SIK2 | 0.40565927 |
| 125 | CAMK1G | 0.40182720 |
| 126 | PHKG2 | 0.39861114 |
| 127 | PHKG1 | 0.39861114 |
| 128 | CSNK1D | 0.39272246 |
| 129 | NME2 | 0.38851086 |
| 130 | NME1 | 0.38004380 |
| 131 | PLK2 | 0.37561881 |
| 132 | CDK9 | 0.37422173 |
| 133 | FLT3 | 0.37049441 |
| 134 | MAP2K1 | 0.37006172 |
| 135 | IGF1R | 0.36716135 |
| 136 | SRPK1 | 0.36306915 |
| 137 | PIM1 | 0.34194753 |
| 138 | ERBB2 | 0.33921677 |
| 139 | ABL1 | 0.33178704 |
| 140 | PRKCQ | 0.32577687 |
| 141 | SYK | 0.32384247 |
| 142 | STK24 | 0.31831691 |
| 143 | RPS6KB1 | 0.28421536 |
| 144 | PRKCH | 0.28238773 |
| 145 | CSK | 0.27878891 |
| 146 | PRKACA | 0.27756768 |
| 147 | VRK1 | 0.27411005 |
| 148 | BRAF | 0.27319825 |
| 149 | PRKAA2 | 0.27295305 |
| 150 | CAMK2A | 0.26799716 |
| 151 | MKNK1 | 0.25722840 |
| 152 | PRKG1 | 0.25718235 |
| 153 | AKT1 | 0.25026707 |
| 154 | MAP2K2 | 0.24954908 |
| 155 | PRKCD | 0.24839520 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.49318559 |
| 2 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.47111521 |
| 3 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 2.27923944 |
| 4 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 2.17556968 |
| 5 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.10437788 |
| 6 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.07692163 |
| 7 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 2.06562194 |
| 8 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.00286959 |
| 9 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.99922396 |
| 10 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.94802325 |
| 11 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.91594968 |
| 12 | Malaria_Homo sapiens_hsa05144 | 1.86340477 |
| 13 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.86058186 |
| 14 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.81356967 |
| 15 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.79268304 |
| 16 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.78851061 |
| 17 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.78131515 |
| 18 | Phototransduction_Homo sapiens_hsa04744 | 1.75250249 |
| 19 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.71624045 |
| 20 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.67875895 |
| 21 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.66857192 |
| 22 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.63376525 |
| 23 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.62325576 |
| 24 | Other glycan degradation_Homo sapiens_hsa00511 | 1.61981374 |
| 25 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.61701729 |
| 26 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.61272066 |
| 27 | Taste transduction_Homo sapiens_hsa04742 | 1.60939020 |
| 28 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.53615693 |
| 29 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.53300693 |
| 30 | Circadian rhythm_Homo sapiens_hsa04710 | 1.52760754 |
| 31 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.51909430 |
| 32 | Allograft rejection_Homo sapiens_hsa05330 | 1.50585049 |
| 33 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.49723320 |
| 34 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.48581648 |
| 35 | Nicotine addiction_Homo sapiens_hsa05033 | 1.46671098 |
| 36 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.46229082 |
| 37 | ABC transporters_Homo sapiens_hsa02010 | 1.42946834 |
| 38 | Measles_Homo sapiens_hsa05162 | 1.41235251 |
| 39 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.40628961 |
| 40 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.33498137 |
| 41 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.31421842 |
| 42 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.31238130 |
| 43 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.30561940 |
| 44 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.30493617 |
| 45 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.29687025 |
| 46 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.25215198 |
| 47 | Morphine addiction_Homo sapiens_hsa05032 | 1.25169939 |
| 48 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.23493237 |
| 49 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.20707924 |
| 50 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.20389324 |
| 51 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.16425525 |
| 52 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.14976413 |
| 53 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.10805123 |
| 54 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.07178649 |
| 55 | Asthma_Homo sapiens_hsa05310 | 1.05813398 |
| 56 | Histidine metabolism_Homo sapiens_hsa00340 | 1.05612639 |
| 57 | Homologous recombination_Homo sapiens_hsa03440 | 1.05611069 |
| 58 | Renin secretion_Homo sapiens_hsa04924 | 1.05099291 |
| 59 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.04281406 |
| 60 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.04031970 |
| 61 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.03707106 |
| 62 | Influenza A_Homo sapiens_hsa05164 | 1.01024086 |
| 63 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.99013120 |
| 64 | Leishmaniasis_Homo sapiens_hsa05140 | 0.98850850 |
| 65 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.98110678 |
| 66 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.96515640 |
| 67 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.95371203 |
| 68 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.94139530 |
| 69 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.92045496 |
| 70 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.90930309 |
| 71 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.90843367 |
| 72 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.90247021 |
| 73 | Pertussis_Homo sapiens_hsa05133 | 0.88816388 |
| 74 | Lysine degradation_Homo sapiens_hsa00310 | 0.88397281 |
| 75 | Insulin secretion_Homo sapiens_hsa04911 | 0.86683860 |
| 76 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.84849018 |
| 77 | Peroxisome_Homo sapiens_hsa04146 | 0.83154857 |
| 78 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.82661126 |
| 79 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.82080645 |
| 80 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.81866633 |
| 81 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.81542587 |
| 82 | Phagosome_Homo sapiens_hsa04145 | 0.79865810 |
| 83 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.79013893 |
| 84 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.77598197 |
| 85 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.74825206 |
| 86 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.73380301 |
| 87 | Legionellosis_Homo sapiens_hsa05134 | 0.73171082 |
| 88 | Protein export_Homo sapiens_hsa03060 | 0.72566891 |
| 89 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.72301622 |
| 90 | Long-term depression_Homo sapiens_hsa04730 | 0.70760220 |
| 91 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.69588801 |
| 92 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.68912396 |
| 93 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.67905454 |
| 94 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.66422922 |
| 95 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.64989701 |
| 96 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.64369900 |
| 97 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.64013726 |
| 98 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.62687138 |
| 99 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.62202450 |
| 100 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.62185854 |
| 101 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.62154750 |
| 102 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.62152012 |
| 103 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.61644461 |
| 104 | RNA degradation_Homo sapiens_hsa03018 | 0.61607175 |
| 105 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.61561375 |
| 106 | Tuberculosis_Homo sapiens_hsa05152 | 0.61479694 |
| 107 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.61421160 |
| 108 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.60791025 |
| 109 | Lysosome_Homo sapiens_hsa04142 | 0.60609659 |
| 110 | Olfactory transduction_Homo sapiens_hsa04740 | 0.60493959 |
| 111 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.60150827 |
| 112 | Circadian entrainment_Homo sapiens_hsa04713 | 0.59598910 |
| 113 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.59421850 |
| 114 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.57459797 |
| 115 | Hepatitis C_Homo sapiens_hsa05160 | 0.55856337 |
| 116 | Retinol metabolism_Homo sapiens_hsa00830 | 0.53965075 |
| 117 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.52612002 |
| 118 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.52502502 |
| 119 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.52038858 |
| 120 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.50777149 |
| 121 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.49569099 |
| 122 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.49280421 |
| 123 | Purine metabolism_Homo sapiens_hsa00230 | 0.49170406 |
| 124 | Mineral absorption_Homo sapiens_hsa04978 | 0.48034252 |
| 125 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.47795831 |
| 126 | Apoptosis_Homo sapiens_hsa04210 | 0.47565112 |
| 127 | RNA polymerase_Homo sapiens_hsa03020 | 0.47470637 |
| 128 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.47326609 |
| 129 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.46883003 |
| 130 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.46176130 |
| 131 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.46012960 |
| 132 | Cocaine addiction_Homo sapiens_hsa05030 | 0.44742991 |
| 133 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.44210647 |
| 134 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.43297422 |
| 135 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.43256402 |
| 136 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.41926864 |
| 137 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.41674482 |
| 138 | Basal transcription factors_Homo sapiens_hsa03022 | 0.41447839 |
| 139 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.40815778 |
| 140 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.40639058 |
| 141 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.40623125 |
| 142 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.40442778 |
| 143 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.39476088 |
| 144 | GABAergic synapse_Homo sapiens_hsa04727 | 0.37259792 |
| 145 | Platelet activation_Homo sapiens_hsa04611 | 0.35773801 |
| 146 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.34520852 |
| 147 | Salivary secretion_Homo sapiens_hsa04970 | 0.34416659 |
| 148 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.34318309 |
| 149 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.32964654 |

